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Abstract: The ultimate quest in the pharmaceutical sector is Product Quality. We aim with this work to guarantee 
conformity between production and Marketing Authorizations data (Authorizations to Make to Market: 
AMM in Europe). These MA detail the process for manufacturing the medicine and compliance to the 
requirements imposed by health organisations like Food and Drug Administration (FDA) and Committee for 
Medicinal Products for Human use (CHMP).  
The paper deals with the communication between heterogeneous information systems with different 
business structures and concepts. The goal is to maintain compliance of technical data in production with 
corresponding regulatory definition of pharmaceutical data in the MA.  
Our approach to modelling present an Interoperability Framework based on a multi-layer separation to 
identify the organisational aspects, business trades, information systems and technologies for each involved 
entity into communication between these two systems. We have used RM-ODP Reference Model for the 
characterisation of each layer. Interoperability is guaranteed if communication of product data respects these 
levels.  
In this work, we are also focus on the meaning of concepts and terms used by integrate business constraints 
in the data structure and their transformation into rules. This helps to identify integration rules to perform 
connections between data and their native information system and communication rules, as transformation 
and correspondence, to ensure the mapping through all product states.  
1 INTRODUCTION 
The pharmaceutical industry is distinguished among 
process industries by the need to comply with 
regulatory constraints imposed by organizations like 
Food and Drug Administration (FDA) [1], 
Committee for Medicinal Products for Human uses 
(CHMP), the guidelines of International the 
Conference of Harmonisation (ICH) [2]. Further 
constraints are imposed by the conventions signed 
with national and international authorities, called 
Marketing Authorisation (MA) – Authorization to 
Make to Market (AMM) in Europe – for the 
manufacture of drugs. 
In this operating context, the issue of product 
quality is one of high priority for a company in order 
to maintain its credibility compared to its customers. 
One of the key factors of quality is the good 
management of product data.  Product data comes in 
several types and formats specific to various 
business trades and are supported by several 
heterogeneous information systems.  The challenge 
is to enable communication among these systems 
and the process of guaranteeing the validity and the 
conformity of exchanged information. This 
challenge is seldom addressed systematically. 
Indeed, considering the complexity of information 
systems architectures for the production, there is a 
general tendency to check conformance only 
between the AMM files and the Standard Working 
Instructions (SWI). 
Our Scope in this paper covers the problem of 
communicating product data between information 
system supporting the MA and the ERP for 
structuring production data. Deliver one product 
according to his description in the MA requires that 
we have the right information in the ERP; otherwise, 
we risk manufacturing a non compliant product, not 
delivering our product in time to respect customer 
commitments, destroy these product and lost money. 
The pivotal problem of medical data is the 
absence of machine readable structures [3]. Most 
healthcare data is narrative text and often not 
accessible. Generally, relates works [3][4] have 
tendency to treat this problem by structuring drug 
information using XML standards to relating and 
searching drug information using topics Maps. 
Performing data mapping between regulatory and 
industrial product definition present a hard task that 
require regrouping effort from different sectors like 
regulatory affairs, industrial operations, information 
systems … 
Some pharmaceutical industries are specialized 
in biologic development of medicines. The 
implication of a deviation in manufacturing or 
subcontracting can run the gamut from very minor to 
catastrophic.     
Our challenge consists in delivering the right 
product data value through manufacturing states in 
production information system. 
During manufacturing process, the product 
passes from one state to another. For each one, we 
find one or several components and we have to 
validate their corresponding specifications by data 
coming from MA information system. The following 
Figure (Figure 1) presents a hierarchical structuring 
for one product in an ERP. 
 
 
Figure 1: Manufacturing product states and state components. 
 
When we have to ensure compliance for one data 
from MA to ERP, we must find and validate product 
data value for each component through different 
product states.  
Our contribution in this paper is to use a 
modelling approach for the communication between 
information systems in a pharmaceutical 
organization. We also propose a methodology for 
structuring and exchanging product data while 
ensuring their conformance. In the following section 
we present some modelling approaches and adapt 
them to our problem. Further, we propose a data 
exchange structure that ensures conformity between 
information systems. Finally, using our approach we 
present a case study at Sanofi-Pasteur, a developer 
and producer of vaccines for human use. 
2 MODELLING APPROACHES 
2.1 Characteristics of 
pharmaceutical industry 
Characteristic of the pharmaceutical industry the 
information for product data is compiled together 
from information contributed by various functional 
divisions that interact with each other in the creation 
and manufacture of the product. As we can see in 
figure 2, each of the following divisions contributes 
different types of information: 
• Research division: searches for new drugs or 
substances that can contribute to the creation of 
new drugs. At this stage studies conducted are 
reported and indexed in the form reports. 
• Research & Development division: conducts 
directed research, and is interested in the 
development of mixture processes of excipients, 
tests and stability conditions of the final solution 
that can be defined as a drug. The information 
system is used to structure data about clinical 
trials and tests for validity. At this stage, we 
begin to define an explicit product structure. 
• Industrialization division: defines the industrial 
infrastructure which will support the production 
of a defined product quantity on the basis of a 
definition of product solution. At this stage, we 
start to define technical data describing the 
operations of product manufacture and the tools 
used. 
• Production division: deals with planning, 
scheduling and follow-up of production based on 
the data describing industrial infrastructure and 
product composition. At this stage, we identify 
static data compared to external dynamic data 
like work orders and internal generated by the 
enterprise resources planning (ERP) like buying 
orders of raw material. 
• Distribution division: defines the conditions for 
handling the product for customer delivery in 
accordance with the description of the conditions 
of manufacture delivered by R&D division. At 
this stage, product handling information is 
documented. 
 
 
Figure 2: Information system sources in pharmaceutical industry 
 
From one stage to another, product data are 
recorded using a specific structure and format. Each 
local information system is defined in accordance 
with the needs which are relevant to their business 
trades. 
The definition of a product for pharmaceutical 
industry is not tied to physical shape except in the 
packaging stage. 
The company submits to the Health Authorities 
entire product specifications along with documented 
information. These deposed documents constitute 
the request of Marketing Authorization. When health 
authorities approve this request, they give the 
Marketing Authorization (MA). In the delivered 
documents to authorities, it is necessary to present 
all information whose justifies product creation 
process, including pre-clinical tests, clinical trials, 
tests of validities and the appendices such as 
bibliography. Only after the process reaches the 
Industrialisation stage that MA documents can get 
defined. 
Once approved in one country, this MA is used 
as reference document to manufacture product.  It’s 
considered as a contract with the authority of a given 
country by the company that’s respects the 
regulatory constraints. Concerning the American 
market, the FDA is responsible for the checking the 
adequacy of the product delivered and 
manufacturing processes against the acquired 
authorization. 
The major quest of each pharmaceutical 
company is product quality. This objective is 
achieved only by ensuring a better degree of 
conformity between existing information in these 
MA documents and those used for the production. 
In the following sections, we will propose means 
to use the MA data, which can be deciphered only 
by pharmacists, to adapt them to logisticians needs. 
The approach used makes it possible to ensure 
interoperability between the information systems 
supports while satisfying some business constraints. 
2.2 Why interoperability? 
The IEEE standard computer dictionary defines 
interoperability as “the ability of two or more 
systems or components to exchange information and 
to use information that has been exchanged”. Also, 
the EU Software Copyright Directive [5] defines 
interoperability between computing components 
generally to mean “the ability to exchange 
information and mutually to use the information 
which has been exchanged”1. This does not mean 
that each component must perform in the same way, 
or contain all of the same functionality, as every 
other one – interoperability is not a synonym for 
cloning. Rather, interoperability means that the 
components, which may differ in functionality, can 
share information and use that information to 
function in the manner in which they were designed 
to.  
 
The European Interoperability Framework 
definition [5] identifies three separate aspects:  
• Technical – is concerned with defining business 
goals, modelling business processes and bringing 
about the collaboration of administrations that 
wish to exchange information, but that may have 
a different internal organisation and structure for 
their operations. 
• Semantic – is concerned with ensuring that the 
precise meaning of exchanged information is 
understandable by any other application not 
initially developed for this purpose. Semantic 
interoperability enables systems to combine 
received information with other information 
resources and to process it in a meaningful 
manner. 
• Organisational – covers the technical issues of 
linking up computer systems and services. This 
includes key aspects such as open interfaces, 
interconnection services, data integration and 
middleware, data presentation and exchange, 
accessibility and security services 
When we aim to better exchange data between 
information systems, we have to be sure that these 
interoperability types are well identified and 
structured. Therefore, it’s necessary to identify the 
area of our investigation and its specifications: 
structures, business constraints …  
2.3 Ways to achieve interoperability 
Seeking to achieve interoperability among divisions 
in collaborative enterprise, we face three core 
challenges [5]: 
• Heterogeneity, incoherent information 
perspectives, systems and software 
infrastructures, working practices, etc among 
divisions 
                                               
1 Council Directive of 14 May 1991 on the legal protection of 
computer programmes (91/250/EEC); 
• Need for Flexibility, due to need for change and 
exception handling following variation in 
registrations and commitments 
• Complexity, the richness of interdependencies 
with and among divisions, their activities, 
resources and skills.  
Heterogeneity, need for flexibility and complexity 
must be managed at different levels: 
• Knowledge, approaches, methods and skills 
needed for innovation, problem solving and work 
performance, the shared language and frames of 
reference needed for communication. 
• Process, the planning, coordination and 
management of cooperative and interdependent 
activities of resources. 
• Infrastructure, the information formats, software 
tools, and interoperability approaches of the 
participating divisions. 
 
 Knowledge Process Infrastructure 
Heterogeneity 
Communication, establishing 
a common languages and 
meaning across division and 
disciplines 
Process diversity, negotiating 
different rules and procedures 
between the partners 
Interoperability across 
companies’ knowledge 
spaces and enterprise 
architectures (Business, 
Knowledge Software). 
Complexity 
Integrate capabilities, form 
effective teams across 
different local cultures.  
Align views with contents and 
context among and between 
stakeholders and people. 
Work management and 
planning, task assignment, 
coordination and monitoring of 
activities and tasks across 
projects, partners and networks, 
dealing with uncertain 
interdependencies among 
several concurrent activities. 
Enterprise architectures, 
managing project and 
systems portfolios; 
providing new model-
driven approaches for 
solutions design and 
development; avoiding 
futurities (unmanageably 
complex systems) 
Flexibility 
Learning, partners must be 
able to improve practice based 
on common experience 
Supporting both structured and 
ad-hoc work (with evolving 
plans); Handling unforeseen 
exceptions 
Customised and 
personalised support; 
Rapid formation of VEs, 
allowing partners to join 
along the way 
When we try to ensure interoperability between 
information systems in regards of main challenges 
through these levels, we need to identify first 
different concerned entities in the company, their 
characteristics and link between them. To perform 
this task, we have to find an enterprise modelling 
approach bringing out all actors, processes, business 
constraints, work practices, etc. and identifying ties 
between them. 
2.4 Enterprise Modelling 
Approaches 
We can find in literature three main enterprise 
modelling approaches: 
Enterprise Framework and architectures; define a 
framework as a fundamental structure which allows 
defining the main sets of concepts to model and 
build an enterprise. We describe two types of 
frameworks: those for integrating enterprise 
modelling (such as Zachman, CIMOSA, etc.) and 
frameworks for integrating enterprise applications 
(such as ISO 15745, the missing approach, etc.) 
Enterprise Modelling language; can be define as 
the art of “externalising” enterprise knowledge by 
representing the enterprise in term of its organisation 
and operations. There are two categories of 
languages: those defined at high level of abstraction 
as Constructs for enterprise modelling (for example, 
EN/ISO 19440, ODP, UEML,GRAI,…) which are 
independent of the technology of implementation; 
and languages more related to a specific technology 
such as INTERNET technology based languages 
(example, ebXML, etc.). 
Enterprise Knowledge space; based on a new 
technology called Active Knowledge Models 
(AKM) and implement types of views from the 
knowledge dimensions that contain mutual and 
complex dependencies of domains. 
 
As combination of these modelling approaches, 
RM-ODP model (Open Distributed Processing – 
Reference Model) [6] [7] presents a methodology for 
the structuring of distributed services of data 
processing carried out in an environment of 
heterogeneous information systems. 
Our problem is to combine these model objectives in 
the formalization of the systems functionalities to 
ensure communication independently of the tools for 
implementation. In the RM-ODP model, the 
modelling concepts, that contributes to this 
formalization, cover: 
• Basic modelling concepts: the basic concepts are 
concerned with existence and activity: the 
expression of what exists, where it is and what it 
does. 
• Specification concepts: addressing notions such 
as type and class that are necessary for reasoning 
about specifications, the relations between 
specifications, provide general tools for design, 
and establish requirements on specification 
languages. 
• Structuring concepts: builds on the basic 
modelling concepts and the specification 
concepts to address recurrent structures in 
Table 1: The resulting problem space 
distributed systems, and cover such concerns as 
policy, naming, behaviour, dependability and 
communication. 
To these concepts, it is necessary to analyse the 
company according to several view points which 
influence the information structure.  The view points 
included are: 
• The enterprise viewpoint: is concerned with the 
purpose, scope and policies governing the 
activities of the specified system within the 
organization of which it is a part; 
• The information viewpoint: is concerned with the 
kinds of information handled by the system and 
constraints on the use and interpretation of that 
information; 
• The computational viewpoint: is concerned with 
the functional decomposition of the system into a 
set of objects that interact at interfaces – enabling 
system distribution; 
• The engineering viewpoint: is concerned with the 
infrastructure required to support system 
distribution; 
• The technology viewpoint: is concerned with the 
choice of technology to support system 
distribution. 
2.5 How achieve interoperability can 
ensure compliance? 
The modelling of the interconnections between 
information systems using these concepts, and 
various view points, makes it possible to ensure a 
structuring in accordance with definite objectives. 
This structuring is defined in information system 
urbanization (cf. project SUSIE [8]). Figure 3 
presents these various points of view as level of 
abstraction. 
 
Figure 3: levels of information structuring 
 
Interoperability between information systems 
could be defined more finely if this type of 
modelling is undertaken. In an industrial framework, 
structuring business knowledge in an information 
processing system does not imply facilitation of 
communication with another business system. Data 
interpretation changes according to the business and 
the challenge is in the ability to preserve information 
semantics when communicate across these levels.  
These problems also appear when we communicate 
product data coming from two different structuring 
perspectives. A proposition of communication 
architecture between two information systems is 
presented in figure 4. 
 
 
Figure 4: communication architecture between heterogeneous information systems 
 
Building similar interoperability architecture can 
align Business, Knowledge and IT through semantic 
framework to ensure compliance when exchanging 
data. In the following section, we will be building 
our decomposition to present a deployment of an 
architecture of communication adapted to our 
context. 
3 METHODOLOGY TO ENSURE 
CONFORMANCE 
In our context, the objective to establish 
communication between information systems is to 
ensure the conformity of the product data in one 
system in relation to each other. Based on the 
description of information in an MA, it is necessary 
to return product data values to the ERP useful for 
the production. 
3.1 Information system to 
communicate 
In our scope, we identify these two entities involved 
in communication: 
• MA information system: are generally managed 
by the regulatory affairs division and constitute a 
regrouping of information. A MA is composed of 
electronic documents coming from several 
sources and contain for example scanned 
documents, reports and attached papers. The 
semantic structuring of these authorisations 
provides a format and contents harmonized 
according to a pharmaceutical vision. It follows a 
specific format called Common Technical 
Document (CTD) [9] [10], defined by the ICH.  
The Figure 5 presents the model of information 
structuring. It is a 5 modules structure. The fives 
modules in the figure 2 are a) specific customer 
information (module1), b) summary module 
which contains information updated from version 
to another (module2) c) product quality (module 
3) d) non clinical study reports (module 4) and e) 
clinical studies reports (module 5). 
The specificity of the levels of information in the 
MA is not significant for the retrieval and the use 
of the data for production division. Only 
pharmacists seek information from regulatory 
data to answer requests for product data 
consultation. Faced with very large number of 
MA documents that run into thousands of pages, 
makes it very difficult to answer requests for data 
validation. 
• Production information system: was structured 
data necessary for the production.  The ERP 
(Enterprise Resource Planning) system manages 
this data and regrouping complex functionalities 
of “provisioning and scheduling” and generates 
new dynamic data based on product data 
definition. So, non-in conformity product data 
definition, invariably leads to the manufacture of 
a non conforming product. 
 
Figure 5: MA structure: CTD format [10] 
 
Each of these divisions presents a specific vision of 
the product with local knowledge tied to business 
rates. It’s a big challenge to communicate these two 
systems due to the complexity of bringing together 
product definition data coming from heterogeneous 
information systems.  
To ensure this conformity at product data 
definition level, it is necessary to define a 
communication platform to include all perspectives, 
in particular, organisational, business, informational, 
and technical [11]. Our purpose is to present data 
exchange architecture allowing as to translate 
product data definition from regulatory systems to 
production one. 
3.2 Which data we need to 
translate? 
When we analyze information in these two systems, 
it’s difficult to find a common data product 
structure. Between pharmaceutical and operational 
scope, we don’t find necessary the same type or 
meaning of information. Thus, it’s necessary to look 
first for defining what kind of information we need 
to ensure conformance. When fixed, we analyze 
product structure in each system to find issues of 
communication.  
The CTD format of MA presents in module 3 
information about product quality. In this module, 
we can find a pharmaceutical description of the 
product and its various states of manufacture. 
Similar in production, we define another collection 
of product states. These states are not necessarily 
coherent among them or are significant from one 
product to another. The best issues that we find to 
communicate product information from MA to ERP 
repose on structuring product data by states. For 
example, in biologic pharmacy, we define two 
families of product state: biologic states and 
pharmaceutics states, from seeds to final product 
states. The product structure is defined in these two 
systems as a specific series of product states. Our 
problem was translated to ensure conformance of 
data values for each product states from one system 
to another. But there are not the same definition of 
product states and not the same data semantic too. 
For example the shelf life of an intermediate 
substance is 3 years at storage temperature of -70°C 
if it was preserved as is, but -20°C if it is 
lyophilised. The finished product has a 1 year shelf 
life at 5 °C storage temperature. 
We assume that the product has a fixed number 
of states on an information system. It’s necessary to 
identify from production and regulatory information 
system, the entire specification of each state. It 
gathers for each stage, the value to be validated, the 
rules defined formally to extract data from an 
information system and informal business 
constraints helping to ensure the communication.  
We call “product state reference frame”, the 
structuring of one product datum that assign for each 
product state, the data value, rules applied to extract 
data from information system, and business 
constraint helping to understand the choice of data 
value.  For each product state, we need to define also 
same component of the bill of materials of this state. 
For example, when our product present at final state 
two bottles, we need to specify shelf life for these 
two entities. For other example of this product state, 
this information is not significant.  
The application of this reference frame to 
product data consists in seeking, for one data values, 
all states in accordance with rules and business 
constraints already identified.  Figure 6 illustrates 
this structuring. 
 
Figure 6: product states reference frame 
 
This reference frame represents the data profile 
in an information system. It must be updated during 
a potential structural modification and can be 
published in the organization to ensure better 
comprehension and exploitation of product data. 
Each line of this reference frame contains a state 
of product, the value to be validated, the rules which 
allow the extraction and the transformation of the 
data and business constraints for the application of 
these rules. For the information system of the 
production, we also find rules allowing for the 
integration of the new value. 
3.3 Rules definition 
The definition of the rules is a tedious phase and 
requires defining rules at three levels: 
3.3.1 Information system rules in 
production 
They are rules to specify when extract or insert data 
into the information system. Difficulty arises when 
attempting to insert data. Indeed, the information 
systems for production are characterized by the re-
use of product states information. Locking to two 
drugs, it is extremely probable to have the same 
excipients in the pharmaceutical solution. In this 
case, there are invariably one or more specific 
common production states with same coding in the 
system. 
In production, following a request for 
modification of product state data, it is necessary to 
check if this state is also used for another product. 
Considering the complexity of architecture on 
information production system and interconnections 
between information inside, it is tiresome to seek 
products by a simple indication of an intermediate 
state. For example, such request can take two days to 
return an answer that we must sort to find required 
information. If we schematize the product states by a 
tree structure with graphs, the interconnection 
between graphs can be possible with any node 
except the first.  Figure 7 shows an example of these 
interconnections.  Each product has 6 states: S1 to 
S6. 
 
Figure 7: overlap of product states for different 
products in production information system 
 
Integration rules must cover procedures of 
checking of the use of one state, as well as the 
impact of one modification if there are common 
states with other products. The impact of one 
modification or transformation on a data is 
sometimes governed by abstract business 
constraints. For example the date of manufacture of 
a product is calculated starting from the first valid 
test of stability. If we want to change the shelf life of 
a state, the expiry date which is equal to the date of 
manufacture added to the shelf life, must be 
revalidated. This aspect touches primarily on data 
transparency. This is why we planned to add 
informal business trade field in the reference frame 
for each product state to help the mapping the 
reference frame of the information system 
supporting MAs. 
3.3.2 Mapping rules 
They are rules for mapping between product states 
reference frames by establishing links between 
active product states. It is also a regulatory 
pharmaceutical responsibility that is necessary to 
share with production to ensure the coherence of 
rules. The product states are not same across 
information systems and certainly across reference 
frames.  From one product to another, a state may or 
may not exist. We use business knowledge as a 
reference to create these links of communication 
between active states. This knowledge is indexed on 
both MA and production reference frames. 
The mapping rules allow formalizing fields of 
data to be inter-connected (links n .. n) as well as 
transformations to use all of the values of the fields 
in the regulatory reference frame to generate the 
corresponding values in the product states reference 
frame of production. Figure 8 illustrates examples of 
connection modes. One state in the first reference 
frame can correspond to one or more states in the 
second and vice versa. To generate mapping rules, 
we use data and rules from the two reference frames. 
For example, mapping rules can be the sum, the 
average, the min or a data which exist only in one of 
the information systems. 
 
 
 
Figure 8: Mapping links 
3.3.3 Regulatory information systems rules 
According to pharmaceutical data structuring, the 
information system which manages the MA is not 
able to be directly interfaced to the regulatory 
product states reference frame. It is possible to have 
several MA for only one product, and conversely, 
one MA for several products. These characteristics 
are relocated on product states, which increase the 
complexity of the information retrieval.  It is very 
frequent to find for example two product 
authorizations with various destinations (country) or 
presentations (packaging contain) and having a 
common product state but with different value. This 
difference is due to the history of the negotiations 
between the company and health authority about 
MA content. 
4 CASE STUDY 
This case study presents an illustration of a work 
developed with Sanofi Pasteur Company, a firm 
specialised on biologic development and the 
production of vaccines for human use. The purpose 
of this work is to ensure conformance, from MA to 
the ERP, for three data: Site of Manufacturing, Shelf 
Life, and Storage Condition. 
All MA data was structured in e-TRAC (Electronic 
Tracking of Registrations and Commitments) 
information systems. Access to these data is ensured 
through web interface allowing us exporting defined 
report from RA-Cockpit reporting module. As 
presented in figure 9, we can: a) export data for one 
product line to create report b) distribute this report 
by product licence number as criteria to identify 
different product data c) for each product data, 
instantiate three reference frame for regulatory 
product states d) apply mapping rules to generate 
corresponding ERP (here SAP) product states 
reference frame e) use same specific criteria to data 
structuring in SAP to validate data comparing to 
those coming from SAP reference frame. 
 
 
Figure 9: communication Scenario 
4.1 Validate data in SAP 
As mentioned before, it is extremely probable to 
have the same product state in different product 
decomposition, so, we can find the same value for 
the same product state in different SAP reference 
frame. In SAP systems, we identify each entity, 
called item, by one code. There is why, we 
instantiate a second SAP reference Frame with just 
SAP code and data value field. It’s necessary to find 
the code of each product state. Due to specific 
information structuring in SAP in Sanofi-Pasteur 
Company, we can find the item code for the last 
state (final product) and use item code filiations to 
find code for all product states. Actually we have 
two SAP reference frames, one with data value 
coming from mapping rules with regulatory 
reference frame, and the second with data value and 
item code from SAP. We define here some rules of 
coherence: 
• For the same product state, we have necessary 
the same data value, else we notify exception  
• For same item codes in the second SAP reference 
frames we have to find the same value, else we 
notify exception 
• It’s frequent to find two or more MA or 
registrations that differ just by product name 
from one country to another. For example we can 
define GRIPPE vaccines in Europe but when 
structuring product information in regulatory 
information systems, we have to separate product 
by country. When we seek to validate our three 
data for grippe in Europe, we have to find the 
same data value in regulatory reference frame for 
all country in Europe, else we notify exception. 
5 CONCLUSION 
In this paper, we presented a modelling 
methodology for information systems especially 
interested in the structuring and explaining 
dependences between product data in the 
pharmaceutical field. Our objective was to ensure 
data compliance between two information systems, 
one related to the Marketing Authorizations (MA) 
and the other with production, through the 
establishment of communication architecture. Faced 
with information systems, we have chosen to ensure 
mapping between product states information along 
product manufacturing life cycle. In spite of 
differences in the business visions, the product 
remains at the core of information structuring in 
these two systems. 
Applied to Grippe Line Product in Sanofi-
Pasteur Company, proposed concepts provide a very 
interesting solution by ensuring data compliance of 
94,6 % of final products for proposed data (Site of 
Manufacturing, Shelf Life, and Storage Condition). 
Some final products states in the ERP have the same 
definition, but not the same utility because they refer 
to product with different quality level. Actually we 
have to treat manually these specific products.  
Our methodology is based in analysing 
information coming from MA information systems 
to validate him in the ERP. But what about product 
data in the ERP not concerned by these concepts? 
How to find him? And which criteria are needed to 
cover him by defined concepts. 
We aim, with the next step of this work, to 
optimise our methodology of communication by 
adding more rules and more constraints, not only to 
extract or integrate data through reference frame, but 
between product states in one reference frame also. 
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